Empowered Funds LLC increased its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 53.0% during the first quarter, HoldingsChannel reports. The fund owned 24,470 shares of the semiconductor company’s stock after buying an additional 8,481 shares during the period. Empowered Funds LLC’s holdings in Synopsys were worth $9,702,000 at the end of the most recent reporting period.
Other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in shares of Synopsys by 1.6% during the 4th quarter. Vanguard Group Inc. now owns 18,464,862 shares of the semiconductor company’s stock worth $8,673,315,000 after purchasing an additional 283,677 shares in the last quarter. State Street Corp increased its holdings in shares of Synopsys by 0.3% in the 4th quarter. State Street Corp now owns 8,788,890 shares of the semiconductor company’s stock valued at $4,128,317,000 after purchasing an additional 28,532 shares in the last quarter. Morgan Stanley lifted its stake in shares of Synopsys by 2.5% in the fourth quarter. Morgan Stanley now owns 4,573,980 shares of the semiconductor company’s stock valued at $2,148,491,000 after purchasing an additional 109,917 shares during the period. Geode Capital Management LLC lifted its stake in shares of Synopsys by 1.3% in the fourth quarter. Geode Capital Management LLC now owns 4,310,846 shares of the semiconductor company’s stock valued at $2,017,256,000 after purchasing an additional 54,329 shares during the period. Finally, Van ECK Associates Corp boosted its holdings in Synopsys by 17.0% during the fourth quarter. Van ECK Associates Corp now owns 2,593,619 shares of the semiconductor company’s stock worth $1,218,275,000 after buying an additional 376,711 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Synopsys Price Performance
Shares of NASDAQ SNPS opened at $372.33 on Friday. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. The company’s 50-day moving average price is $446.60 and its 200 day moving average price is $451.11. Synopsys, Inc. has a 52 week low of $366.00 and a 52 week high of $646.28. The stock has a market cap of $71.29 billion, a price-to-earnings ratio of 86.19, a PEG ratio of 2.20 and a beta of 1.22.
Insider Buying and Selling
In related news, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer directly owned 14,358 shares in the company, valued at $6,461,387.16. The trade was a 19.12% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the sale, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Company insiders own 0.56% of the company’s stock.
Wall Street Analyst Weigh In
Several research analysts have weighed in on the stock. Zacks Research upgraded shares of Synopsys from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, June 30th. Stifel Nicolaus boosted their price target on Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Weiss Ratings restated a “hold (c-)” rating on shares of Synopsys in a report on Monday, June 8th. Benchmark assumed coverage on Synopsys in a research note on Wednesday, July 15th. They issued a “buy” rating and a $570.00 price objective for the company. Finally, BNP Paribas Exane lifted their price objective on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a report on Thursday, May 28th. Two analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $570.06.
View Our Latest Analysis on Synopsys
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Read More
- Five stocks we like better than Synopsys
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
